Loading…

Moderate fixed‐dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial

Saved in:

Bibliographic Details
Published in:	American journal of hematology 2020-09, Vol.95 (9), p.E247-E250
Main Authors:	Galadanci, Najibah A., Abdullahi, Shehu U., Ali Abubakar, Shehi, Wudil Jibir, Binta, Aminu, Hauwa, Tijjani, Aliyu, Abba, Muhammad S., Tabari, Musa A., Galadanci, Aisha, Borodo, Awwal Musa, Belonwu, Raymond, Salihu, Auwal S., Rodeghier, Mark, Ghafuri, Djamila L., Covert C Greene, Brittany V., Neville, Kathleen, Kassim, Adetola A., Kirkham, Fenella J., Jordan, Lori C., Aliyu, Muktar H., DeBaun, Michael R.
Format:	Article
Language:	English
Subjects:	Anemia, Sickle Cell - drug therapy Child Child, Preschool Female Hematology Humans Hydroxyurea Hydroxyurea - administration & dosage Hydroxyurea - adverse effects Male Nigeria Sickle cell disease Stroke - prevention & control
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!